期刊文献+

克隆并构建人骨形成蛋白2真核表达载体 被引量:11

CLONING AND CONSTRUCTING OF BONE MORPHOGENETIC PROTEIN 2 EUKARYOTIC EXPERSSION VECTOR
下载PDF
导出
摘要 目的探讨构建人骨形成蛋白2(humanbonemorphgeneticprotein2,hBMP-2)真核表达载体的方法。方法由人成骨肉瘤细胞中提取细胞总RNA,利用RT-PCR方法扩增获得hBMP-2基因cDNA,将基因片断重组到pGEM-T质粒中构建pGEM-T-hBMP-2重组质粒载体,转化到大肠杆菌DH5α后筛选阳性克隆,利用限制性酶切和DNA序列分析鉴定重组质粒。分别用EcoR和Not双酶切pGEM-T-hBMP-2质粒和pcDNA3.1(+)真核表达载体,将克隆载体中hBMP基因重组到pcDNA3.1(+)真核表达载体,提取质粒作酶切电泳、PCR鉴定及DNA测序。结果人骨肉瘤细胞中经RT-PCR得到1.2kbp的hBMP-2扩增条带,重组质粒pGEM-T-hBMP-2经酶切电泳可见1.2kbp的hBMP-2条带和4.0kbp的载体片断;pcDNA3.1-hBMP-2质粒经酶切电泳可见1.2kbp的hBMP-2条带和5.0kbp的载体片断,重组质粒酶谱分析与预期一致;DNA序列分析测序结果校对后经BLAST分析,表明核酸序列与GeneBank中和hBMP-2的mRNA序列完全吻合。结论通过此方法能成功克隆获得hBMP-2基因,并构建其真核表达载体。 Objective To clone human bone morphogenetic protein 2 (BMP-2) gene and construct the gene's eukaryotic expression vector. Methods The total RNA was extracted from human osteosarcoma cells, the human BMP-2 cDNA was amplified by RT PCR and inserted into pGEM-T vector. The positive clones were screened out, and then the recombinant plasmid was confirmed by restriction enzyme digestion, PCR and the analysis of nucleotide sequence. The BMP-2 cDNA in the pGEM T cloning vector was inserted into the pcDNA3.1 (+) eukaryotic expression vector. Results The agarose electrophoresis showed that the fragments of BMP 2, pGEM T and pcDNA3. 1 (+) were 1.2 kbp, 4.0 kbp and 5.0 kbp, respectively. The result of nucleotide sequence confirmed that the cDNA sequence, which was inserted into pGEM T and pcDNA3. 1 (+) plasmid was human BMP-2. Conclusion The pcDNA3. 1 (+)- hBMP-2 eukaryotic vector can be successfully constructed.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2006年第2期112-115,共4页 Chinese Journal of Reparative and Reconstructive Surgery
基金 贵州省科技基金资助项目(20052053) 贵州省特助经费资助项目(200514)~~
关键词 骨形成蛋白2 真核表达载体 基因克隆 Bone morphogenetic protein 2 Eukaryotic expression vector Gene cloning
  • 相关文献

参考文献4

二级参考文献52

  • 1Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol, 1998,16(3):247-252.
  • 2Harris WH. Management of the deficient acetabulum using cementless fixation without bone grafting.Orthop Clin North Am, 1993,24(4):663-665.
  • 3Gungormus M, Kaya O. Evaluation of the effect of heterologous type I collagen on healing of bone defects.J Oral Maxillofac Surg, 2002,60(5):541 -545.
  • 4Solheim E. Growth factors in bone.Int Orthop, 1998,22(6):410-416.
  • 5De Groot J. Carriers that concentrate native bone morphogenetic protein in vivo. Tissue Eng, 1998,4(4):337-341.
  • 6Salkeld SL, Patron LP, Barrack RL, et al.The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone.J Bone Joint Surg (Am), 2001,83(6):803-816.
  • 7Yu TT, Shoichet MS. Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering.Biomaterials 2005; 26:1507-14.
  • 8Cheng MH, Brey EM, Allori A, Satterfield WC, Chang DW, Patrick CW Jr, et al. Ovine model for engineering bone segments. Tissue Eng 2005; 11: 214-25.
  • 9Choo AB, Padmanabhan J, Chin AC, Oh SK. Expansion of pluripotent human embryonic stem cells on human feeders.Biotechnol Bioeng 2004: 88: 321-31.
  • 10Hsu SH, Tsai CL, Tang CM. Evaluation of cellular affinity and compatibility to biodegradable polyesters and type-II collagenmodified scaffolds using immortalized rat chondrocytes. Artif Organs 2002; 26: 647-58.

共引文献106

同被引文献144

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部